Frankfurt
12.11.25 | 08:02
0,070 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,096 | 0,100 | 10:52 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:19 | XFRA 1MK: AUSSETZUNG/SUSPENSION | 91 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILMAUNA KEA TECHNOL.EO... ► Artikel lesen | |
| 07:48 | Mauna Kea Technologies Exits Safeguard Proceedings Following Court Approval of its Plan and Initiates Minimum €5M Capital Raise | 168 | Business Wire | Safeguard plan approved by judgment of the Paris Commercial Court on November 12, 2025 Launch of a reserved capital increase in the form of shares with attached warrants (ABSA) at a price of... ► Artikel lesen | |
| 06.11. | Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital | 213 | Business Wire | Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMF
Regulatory News:
Mauna Kea Technologies (Paris:ALMKT):
Listing: Euronext Growth Paris
ISIN... ► Artikel lesen | |
| 21.10. | Mauna Kea Technologies Announces It Has Secured Over €5M in Firm Subscription Commitments as Required for Its Capital Increase | 349 | Business Wire | New equity financing would provide the Company sufficient financial visibility to execute its strategic plan and achieve profitability The future exercise of share subscription warrants (BSA)... ► Artikel lesen | |
| 13.10. | Mauna Kea Technologies Reports Third Quarter 2025 Revenue Up +16% at Constant Exchange Rates | 213 | Business Wire | U.S. sales surge +31% at constant exchange rates, with continued acceleration over the year Commercial momentum highlighted by a doubling of U.S. system sales year-to-date Adding to U.S. commercial... ► Artikel lesen | |
| 08.10. | Mauna Kea Technologies Announces the Terms of its Financing Under its Safeguard Plan | 445 | Business Wire | Capital increase of €5m to €8m through a private placement planned for the first half of November via the issuance of shares with attached warrants (ABSA) Firm commitment from an investor for... ► Artikel lesen | |
| MAUNA KEA TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 06.10. | Mauna Kea Technologies Reaches a Key Milestone in Its Financial Restructuring | 845 | Business Wire | A large majority of creditors and shareholders have voted in favor of the draft safeguard plan This plan includes a 70% reduction in debt, from €40 million to €12 million, with a payment schedule... ► Artikel lesen | |
| 02.10. | Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital | 280 | Business Wire | Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMF
Regulatory News:
Mauna Kea Technologies (Paris:ALMKT):
Listing: Euronext Growth Paris
ISIN... ► Artikel lesen | |
| 01.10. | Mauna Kea Technologies Announces 2025 Half-Year Results | 318 | Business Wire | 32% Reduction in H1 2025 Current Operating Loss excluding [Non-cash] Share-based Payments Improvement Reflects Strict Expense Control and 17% U.S. Sales Growth1 Finalization of Safeguard Plan... ► Artikel lesen | |
| 22.09. | Mauna Kea Technologies Presents the Final Terms of its Safeguard Plan | 392 | Business Wire | Reduction of the Company's debt from €40 million to €12 million, spread over 10 years Capital increase of at least €5 million post-plan adoption, with the issuance of stock warrants (BSAs) to... ► Artikel lesen | |
| 18.09. | Mauna Kea Technologies and Endotherapeutics Announce Cellvizio First Australian Orders, Advancing CellTolerance Commercial Expansion | 562 | Business Wire | Regulatory News:
Mauna Kea Technologies (Euronext Growth: ALMKT) and Endotherapeutics, today announced that Cellvizio system has been included in the Australian Register of Therapeutic Goods... ► Artikel lesen | |
| 12.09. | Mauna Kea Technologies Unveils the Outlines of its Safeguard Plan to Ensure its Turnaround | 685 | Business Wire | Shareholders, holders of securities giving access to the capital, and creditors of Mauna Kea Technologies convened into classes of affected parties to vote on the safeguard plan
Regulatory News:... ► Artikel lesen | |
| 08.09. | Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio | 313 | Business Wire | New letter published by the AFS highlights Cellvizio's superiority to conventional tools for detecting pre-cancerous tissue and dysplasia
Regulatory News:
Mauna Kea Technologies (Euronext... ► Artikel lesen | |
| 08.09. | Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital | 251 | Business Wire | Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMF
Regulatory News:
Mauna Kea Technologies (Paris:ALMKT):
Listing: Euronext Growth Paris
ISIN... ► Artikel lesen | |
| 29.08. | Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital | 543 | Business Wire | Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMF
Regulatory News:
Mauna Kea Technologies (Paris:ALMKT):
Listing: Euronext Growth Paris
ISIN... ► Artikel lesen | |
| 28.07. | Mauna Kea Technologies Reports First Half 2025 Revenue | 485 | Business Wire | On Constant Currency Basis (CER), U.S. sales up +17% Y/Y in H1 and +23% in Q2 Record U.S. sales productivity despite ongoing safeguard procedure Total revenue down 5% amid weaker EMEA and... ► Artikel lesen | |
| 24.07. | Mauna Kea Technologies Enters Australian Market with Endotherapeutics Partnership | 556 | Business Wire | Leveraging strong momentum for the CellTolerance® application, Mauna Kea Technologies is expanding into new geographies with high growth potential Regulatory clearance in Australia (TGA) expected... ► Artikel lesen | |
| 21.07. | Mauna Kea Technologies Strengthens its Leading Role in the AI-based Endomicroscopic Imaging Ecosystem with its 14th Patent Granted in the U.S. | 644 | Business Wire | 14th U.S. AI patent awarded complementing a comprehensive portfolio of AI-related intellectual property An ecosystem built around the Cellvizio® platform, enabling partners to develop advanced... ► Artikel lesen | |
| 15.07. | Mauna Kea Technologies Congratulates Stanford Health Care on Completing 100 Food Intolerance Cases with Cellvizio | 590 | Business Wire | Clinical team at Stanford Health Care achieved the CellTolerance 100-case milestone with the Cellvizio® platform in less than 6 months The CellTolerance® test offers IBS patients a way to detect... ► Artikel lesen | |
| 10.07. | Mauna Kea Technologies Extends Its Financial Horizon Beyond the Observation Period of the Safeguard Procedure | 882 | Business Wire | Bridge financing through the issuance of convertible bonds to Vester Finance and European investors for €1.8m Immediate receipt of the entire financing upon signing Cash runway extended to... ► Artikel lesen |
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,089 | -3,26 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
| FAMICORD | 5,350 | 0,00 % | EQS-Adhoc: FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. erwirbt 100 % der Anteile an der Stammzellbank 'nOvum' spólka z ograniczona odpowiedzialnoscia, Warschau, Polen | EQS-Ad-hoc: FamiCord AG / Schlagwort(e): Fusionen & Übernahmen
FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. erwirbt 100 % der Anteile an der Stammzellbank 'nOvum' spólka z ograniczona... ► Artikel lesen | |
| GERATHERM MEDICAL | 3,510 | +0,29 % | Geratherm Medical AG: Starkes Wachstum im ersten Halbjahr und operatives Break-even; KAUFEN bestätigt. | Geratherm verzeichnete im ersten Halbjahr 2025 ein starkes Wachstum: Die vergleichbaren Umsätze stiegen um 13,2 % gegenüber dem Vorjahr und sequenziell um 15,4 %. Getrieben wurde dieses Wachstum von... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,551 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Highlights ReSPECT-LM Clinical Trial Results at 40th SITC Annual Meeting, Melanoma Research Foundation Brain Metastases Summit 4.0 | ||
| MEDICLIN | 3,480 | -0,57 % | EQS-News: MEDICLIN AG: MEDICLIN auf Kurs: Geschäftsentwicklung im Rahmen der Erwartungen | EQS-News: MEDICLIN AG
/ Schlagwort(e): 9-Monatszahlen/Sonstiges
MEDICLIN auf Kurs: Geschäftsentwicklung im Rahmen der Erwartungen
04.11.2025 / 14:13 CET/CEST
Für den... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,704 | -0,28 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update | Company reports progress to file planned IND for (Z)-endoxifen in mBC with CRO selection and streamlined development programs for potential 2026-NDA enabling activities... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Announces Voting Results from Special Meeting of Stockholders / Evofem Shareholders Did Not Approve the Merger with Aditxt | -- Evofem Shareholders Did Not Approve the Merger with Aditxt --
-- Evofem Pivots to Target National Listing for Stock, Growth Capital to Catalyze Net Sales... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf | BOULDER, CO / ACCESS Newswire / November 6, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous... ► Artikel lesen | |
| VERU | 2,710 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
| LIFEWARD | 0,529 | 0,00 % | Lifeward Ltd.: Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| LIGHT AI | 0,138 | -2,13 % | Light AI reports Q3 results | ||
| MAVEN BRANDS | 0,001 | 0,00 % | Maven Brands Inc: Maven Brands to sell subdivided Lumby land for $3.5M | ||
| SIEMENS HEALTHINEERS | 43,840 | -2,19 % | DAX stabil: HV bei Tesla, Commerzbank, DHL, Rheinmetall, BMW, VW, Siemens Healthineers im ... | Der DAX hat am Mittwoch in die Gewinnzone drehen können. Am Ende ging er mit einem Plus von 0,4 Prozent bei 24.049,74 Zählern aus dem Handel. Zum Start in den Donnerstag dürfte er jedoch zunächst auf... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,440 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| FRESENIUS | 49,340 | -0,86 % | Fresenius: Gewinnmitnahmen nach den Zahlen - und nun? | Fresenius hat am Mittwoch im dritten Quartal mehr verdient als erwartet, vor allem dank der guten Entwicklung der Tochtergesellschaft Kabi. Vorstandschef Michael Sen hob deshalb die Gewinnprognose für... ► Artikel lesen |
MAUNA KEA TECHNOLOGIES gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,070 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MAUNA KEA TECHNOLOGIES finden Sie auf Wallstreet Online.